Sydney Blattman is a postdoctoral researcher in the laboratory of Dana Pe'er at Memorial Sloan Kettering (MSK) Cancer Center. During her Ph.D., Blattman studied phenotypic heterogeneity in bacterial populations. She developed PETRI-seq, the first high-throughput single-cell sequencing technology for microbes.
Read more